Is Your Child's Allowance Undermining Your Retirement?
The $1,000 Challenge, Part 9: Nibbling Away at the Family Food Bills
The Benefits of Filing Your Taxes Early
After Market: Stocks Finish Wild Week with a Whimper
MultiStem Overshadows Q4 Loss at Athersys - Analyst Blog
Athersys' CEO Discusses Q4 2013 Results - Earnings Call Transcript
Recent Developments Do Not Justify Athersys' Doubling Since December
2 Cell Therapy Companies That Could Thrive With Cardiovascular Disease Treatments
Athersys: Two Crucial Near-Term Events
Neuralstem, StemCells, Inc., And Athersys, Inc. - Making Early Headlines In 2014
Athersys-Pfizer Investors: Anticipating A Phase III Trial For Inflammatory Bowel Disease
Athersys, Inc. And The Future Of Regenerative Medicine
Athersys: Why Did Shareholders Come Knocking At The Door Once Again?
Vital Stem Cell Data And Development Coming In 2014